Antònia Agustí

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital

Antonio Vallano, Consuelo Pedrós, Antònia Agustí et al. · British Journal of Clinical Pharmacology · 2005 · 227 citations · Full text

Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States

Carolina Iglesias-López, Antònia Agustí, Mercè Obach et al. · Frontiers in Pharmacology · 2019 · 188 citations · Full text

Engineering, Pathology, Biological Therapy +21

Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors

Antonio San-José, Antònia Agustí, Xavier Vidal et al. · BMC Geriatrics · 2015 · 83 citations · Full text

An Intervention to Improve Spontaneous Adverse Drug Reaction Reporting by Hospital Physicians

Consuelo Pedrós, Antonio Vallano, Gemma Mendoza-Aran et al. · Drug Safety · 2009 · 83 citations

Drug Safety, Drug Hypersensitivity, Adverse Event +8